• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Pathophysiology of dyslipidaemia in the metabolic syndrome.代谢综合征血脂异常的病理生理学
Postgrad Med J. 2005 Jun;81(956):358-66. doi: 10.1136/pgmj.2004.025601.
2
Dyslipidaemia, hypercoagulability and the metabolic syndrome.血脂异常、高凝状态与代谢综合征。
Curr Vasc Pharmacol. 2006 Jul;4(3):175-83. doi: 10.2174/157016106777698432.
3
Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.超越低密度脂蛋白:应对2型糖尿病和代谢综合征中的致动脉粥样硬化脂质三联征。
Am J Cardiovasc Drugs. 2005;5(6):379-87. doi: 10.2165/00129784-200505060-00005.
4
Diabetic dyslipidaemia.糖尿病血脂异常
Diabetes Obes Metab. 2000 Mar;2 Suppl 1:S31-6. doi: 10.1046/j.1463-1326.2000.00021.x.
5
Nicotinic acid in the management of dyslipidaemia associated with diabetes and metabolic syndrome: a position paper developed by a European Consensus Panel.烟酸在糖尿病和代谢综合征相关血脂异常管理中的应用:欧洲共识小组制定的立场文件
Curr Med Res Opin. 2005 May;21(5):665-82. doi: 10.1185/030079905x43677.
6
Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.2型糖尿病血管功能障碍的机制、意义及治疗:聚焦于调脂治疗
Drugs. 2005;65(1):31-74. doi: 10.2165/00003495-200565010-00003.
7
Lipoprotein distribution in the metabolic syndrome, type 2 diabetes mellitus, and familial combined hyperlipidemia.代谢综合征、2型糖尿病和家族性混合型高脂血症中的脂蛋白分布
Am J Cardiol. 2003 Aug 18;92(4A):27J-33J. doi: 10.1016/s0002-9149(03)00613-1.
8
[Diabetic dyslipidaemia and the atherosclerosis].[糖尿病血脂异常与动脉粥样硬化]
Orv Hetil. 2016 May 8;157(19):746-52. doi: 10.1556/650.2016.30441.
9
Lipid therapy for cardiovascular disease with insulin resistance, diabetes, or the metabolic syndrome.用于治疗伴有胰岛素抵抗、糖尿病或代谢综合征的心血管疾病的脂质疗法。
Curr Cardiol Rep. 2005 Nov;7(6):457-64. doi: 10.1007/s11886-005-0064-9.
10
Free fatty acid metabolism during fenofibrate treatment of the metabolic syndrome.非诺贝特治疗代谢综合征期间的游离脂肪酸代谢
Clin Pharmacol Ther. 2003 Sep;74(3):236-44. doi: 10.1016/S0009-9236(03)00170-X.

引用本文的文献

1
Data-driven cluster analysis of lipids, inflammation, and aging in relation to new-onset type 2 diabetes mellitus.与新发2型糖尿病相关的脂质、炎症和衰老的数据驱动聚类分析。
Endocrine. 2025 Apr;88(1):151-161. doi: 10.1007/s12020-024-04154-y. Epub 2025 Jan 2.
2
Impact of oil type on the development and oral bioavailability of self-nanoemulsifying drug delivery systems containing simvastatin.油种类对包含辛伐他汀的自微乳药物传递系统的发展和口服生物利用度的影响。
Sci Rep. 2024 Sep 29;14(1):22584. doi: 10.1038/s41598-024-71980-5.
3
Totum-070, a Polyphenol-Rich Plant Extract, Prevents Hypercholesterolemia in High-Fat Diet-Fed Hamsters by Inhibiting Intestinal Cholesterol Absorption.多酚丰富的植物提取物 Totum-070 通过抑制肠道胆固醇吸收预防高脂饮食喂养的仓鼠的高胆固醇血症。
Nutrients. 2023 Dec 9;15(24):5056. doi: 10.3390/nu15245056.
4
Clinical utility of lipid ratios as potential predictors of metabolic syndrome among the elderly population: Birjand Longitudinal Aging Study (BLAS).血脂比值作为老年人群代谢综合征潜在预测指标的临床应用:比詹德纵向老龄化研究(BLAS)。
BMC Geriatr. 2023 Jul 3;23(1):403. doi: 10.1186/s12877-023-04040-8.
5
Magnitude and associated factors of dyslipidemia among patients with severe mental illness in dire Dawa, Ethiopia: neglected public health concern.埃塞俄比亚 dire Dawa 严重精神疾病患者血脂异常的程度及其相关因素:被忽视的公共卫生问题。
BMC Cardiovasc Disord. 2023 Jun 13;23(1):298. doi: 10.1186/s12872-023-03327-3.
6
A Polynesianspecific missense CETP variant alters the lipid profile.一个特定于波利尼西亚人的错义 CETP 变体改变了脂质谱。
HGG Adv. 2023 May 8;4(3):100204. doi: 10.1016/j.xhgg.2023.100204. eCollection 2023 Jul 13.
7
Changes in Lipoprotein Particles in the Blood Serum of Patients with Lichen Planus.扁平苔藓患者血清中脂蛋白颗粒的变化
Metabolites. 2023 Jan 6;13(1):91. doi: 10.3390/metabo13010091.
8
Genetics of Cholesterol-Related Genes in Metabolic Syndrome: A Review of Current Evidence.代谢综合征中胆固醇相关基因的遗传学:当前证据综述
Biomedicines. 2022 Dec 13;10(12):3239. doi: 10.3390/biomedicines10123239.
9
Antihyperglycemic and antihyperlipidemic activities of wild musk melon ( var. ) in streptozotocin-nicotinamide induced diabetic rats.野生甜瓜(变种)对链脲佐菌素-烟酰胺诱导的糖尿病大鼠的降血糖和降血脂活性
Chin Herb Med. 2020 Sep 4;12(4):399-405. doi: 10.1016/j.chmed.2020.02.005. eCollection 2020 Oct.
10
Risk for Behçet's disease gauged via high-density lipoprotein cholesterol: a nationwide population-based study in Korea.通过高密度脂蛋白胆固醇评估白塞病风险:韩国全国基于人群的研究。
Sci Rep. 2022 Jul 26;12(1):12735. doi: 10.1038/s41598-022-17096-0.

本文引用的文献

1
Heterozygote men with familial hypercholesterolaemia may have an abnormal triglyceride response post-prandially. Evidence for another predictor of vascular risk in familial hypercholesterolaemia.患有家族性高胆固醇血症的杂合子男性餐后甘油三酯反应可能异常。这是家族性高胆固醇血症中另一种血管风险预测指标的证据。
Int J Clin Pract. 2005 Mar;59(3):311-7. doi: 10.1111/j.1742-1241.2004.00223.x.
2
APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease.载脂蛋白A5基因多态性可调节甘油三酯、高密度脂蛋白胆固醇和富含甘油三酯的高密度脂蛋白水平,但并非冠状动脉疾病的危险因素。
Atherosclerosis. 2004 Sep;176(1):165-72. doi: 10.1016/j.atherosclerosis.2004.04.024.
3
Dyslipidemia in visceral obesity: mechanisms, implications, and therapy.内脏肥胖中的血脂异常:机制、影响及治疗
Am J Cardiovasc Drugs. 2004;4(4):227-46. doi: 10.2165/00129784-200404040-00004.
4
Analysis of candidate genes in Polish families with obesity.波兰肥胖家族中候选基因的分析。
Clin Chem Lab Med. 2004 May;42(5):487-93. doi: 10.1515/CCLM.2004.083.
5
Population-based study of SR-BI genetic variation and lipid profile.基于人群的SR-BI基因变异与血脂谱研究。
Atherosclerosis. 2004 Jul;175(1):159-68. doi: 10.1016/j.atherosclerosis.2004.03.014.
6
The nicotinic acid receptor--a new mechanism for an old drug.烟酸受体——一种老药的新作用机制。
Lancet. 2004 Jun 5;363(9424):1892-4. doi: 10.1016/S0140-6736(04)16359-9.
7
The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism?载脂蛋白CIII和AV的作用及作用方式:甘油三酯代谢中的协同因子?
Curr Opin Lipidol. 2004 Jun;15(3):239-46. doi: 10.1097/00041433-200406000-00002.
8
A common polymorphism of uncoupling protein 2 gene is associated with hypertension.解偶联蛋白2基因的一种常见多态性与高血压有关。
J Hypertens. 2004 Jan;22(1):97-102. doi: 10.1097/00004872-200401000-00018.
9
Blood pressure in relation to three candidate genes in a Chinese population.中国人群中血压与三个候选基因的关系。
J Hypertens. 2004 May;22(5):937-44. doi: 10.1097/00004872-200405000-00015.
10
Combination therapy for the treatment of dyslipidemia.用于治疗血脂异常的联合疗法。
Curr Opin Investig Drugs. 2004 Mar;5(3):306-12.

代谢综合征血脂异常的病理生理学

Pathophysiology of dyslipidaemia in the metabolic syndrome.

作者信息

Kolovou G D, Anagnostopoulou K K, Cokkinos D V

机构信息

1st Cardiology Department, Onassis Cardiac Surgery Centre, Athens, Greece.

出版信息

Postgrad Med J. 2005 Jun;81(956):358-66. doi: 10.1136/pgmj.2004.025601.

DOI:10.1136/pgmj.2004.025601
PMID:15937200
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1743285/
Abstract

The insulin resistance/metabolic syndrome is characterised by the variable coexistence of hyperinsulinaemia, obesity, dyslipidaemia, and hypertension. The pathogenesis of the syndrome has multiple origins, but obesity and sedentary lifestyle coupled with diet and still largely unknown genetic factors clearly interact to produce the syndrome. Dyslipidaemia, the hallmark of the metabolic syndrome, includes increased flux of free fatty acids, raised triglycerides, apolipoprotein B, and small dense low density lipoprotein, and decreased high density lipoprotein cholesterol. The widely prevalent nature of the metabolic syndrome emphasises the importance of its diagnosis and treatment. This review analyses the clinical and dynamic features of this syndrome in the aspect of dyslipidaemia and its management.

摘要

胰岛素抵抗/代谢综合征的特征是高胰岛素血症、肥胖、血脂异常和高血压等多种症状并存。该综合征的发病机制有多种根源,但肥胖、久坐不动的生活方式、饮食以及很大程度上仍不明确的遗传因素显然相互作用,导致了该综合征的发生。血脂异常是代谢综合征的标志,包括游离脂肪酸通量增加、甘油三酯升高、载脂蛋白B和小而密的低密度脂蛋白增加,以及高密度脂蛋白胆固醇降低。代谢综合征的广泛流行凸显了其诊断和治疗的重要性。本综述从血脂异常及其管理方面分析了该综合征的临床和动态特征。